88 related articles for article (PubMed ID: 16685394)
41. [Clinical significance of abnormal expression of Aurora-A in human esophageal squamous cell carcinoma with or without lymph node metastasis].
Shi J; Xue LY; Yin N; Lu J; Fu M; Dong LJ; Shao SJ; Tong T; Zhan QM
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):748-51. PubMed ID: 21163064
[TBL] [Abstract][Full Text] [Related]
42. Clinical significance of LAMB3 and COL7A1 mRNA in esophageal squamous cell carcinoma.
Kita Y; Mimori K; Tanaka F; Matsumoto T; Haraguchi N; Ishikawa K; Matsuzaki S; Fukuyoshi Y; Inoue H; Natsugoe S; Aikou T; Mori M
Eur J Surg Oncol; 2009 Jan; 35(1):52-8. PubMed ID: 18331784
[TBL] [Abstract][Full Text] [Related]
43. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
[TBL] [Abstract][Full Text] [Related]
44. Reduced nuclear and ectopic cytoplasmic expression of lysyl oxidase-like 2 is associated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Li TY; Xu LY; Wu ZY; Liao LD; Shen JH; Xu XE; Du ZP; Zhao Q; Li EM
Hum Pathol; 2012 Jul; 43(7):1068-76. PubMed ID: 22204712
[TBL] [Abstract][Full Text] [Related]
45. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
46. The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.
Usui A; Hoshino I; Akutsu Y; Sakata H; Nishimori T; Murakami K; Kano M; Shuto K; Matsubara H
Cancer; 2012 Jul; 118(13):3387-96. PubMed ID: 22028113
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
48. Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma.
Liu YQ; Li HX; Lou X; Lei JY
Arch Pathol Lab Med; 2008 Aug; 132(8):1307-12. PubMed ID: 18684031
[TBL] [Abstract][Full Text] [Related]
49. Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma.
Konishi S; Ishiguro H; Shibata Y; Kudo J; Terashita Y; Sugiura H; Koyama H; Kimura M; Sato A; Shinoda N; Kuwabara Y; Fujii Y
Cancer; 2002 Dec; 95(12):2473-8. PubMed ID: 12467059
[TBL] [Abstract][Full Text] [Related]
50. Quantitative analysis of heparanase gene expression in esophageal squamous cell carcinoma.
Ikeguchi M; Fukuda K; Yamaguchi K; Kondo A; Tsujitani S; Kaibara N
Ann Surg Oncol; 2003 Apr; 10(3):297-304. PubMed ID: 12679316
[TBL] [Abstract][Full Text] [Related]
51. NOTCH1 expression predicts patient prognosis in esophageal squamous cell cancer.
Ogawa R; Ishiguro H; Kimura M; Funahashi H; Wakasugi T; Ando T; Shiozaki M; Takeyama H
Eur Surg Res; 2013; 51(3-4):101-7. PubMed ID: 24217574
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathological significance of human macrophage metalloelastase expression in esophageal squamous cell carcinoma.
Ding Y; Shimada Y; Gorrin-Rivas MJ; Itami A; Li Z; Hong T; Maeda M; Komoto I; Kawabe A; Kaganoi J; Imamura M
Oncology; 2002; 63(4):378-84. PubMed ID: 12417793
[TBL] [Abstract][Full Text] [Related]
53. Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer.
Terashita Y; Sasaki H; Haruki N; Nishiwaki T; Ishiguro H; Shibata Y; Kudo J; Konishi S; Kato J; Koyama H; Kimura M; Sato A; Shinoda N; Kuwabara Y; Fujii Y
Jpn J Clin Oncol; 2002 Jul; 32(7):238-43. PubMed ID: 12324573
[TBL] [Abstract][Full Text] [Related]
54. Phospho-Sphingosine Kinase 1 Expression in Lymphatic Spread of Esophageal Squamous Cell Carcinoma.
Nemoto M; Ichikawa H; Nagahashi M; Hanyu T; Ishikawa T; Kano Y; Muneoka Y; Wakai T
J Surg Res; 2019 Feb; 234():123-131. PubMed ID: 30527463
[TBL] [Abstract][Full Text] [Related]
55. Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer.
Shibata Y; Haruki N; Kuwabara Y; Nishiwaki T; Kato J; Shinoda N; Sato A; Kimura M; Koyama H; Toyama T; Ishiguro H; Kudo J; Terashita Y; Konishi S; Fujii Y
Jpn J Clin Oncol; 2002 Jul; 32(7):233-7. PubMed ID: 12324572
[TBL] [Abstract][Full Text] [Related]
56. Heparanase expression in clinical digestive malignancies.
Inoue H; Mimori K; Utsunomiya T; Sadanaga N; Barnard GF; Ueo H; Mori M
Oncol Rep; 2001; 8(3):539-42. PubMed ID: 11295076
[TBL] [Abstract][Full Text] [Related]
57. Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.
Mukherjee S; Roth MJ; Dawsey SM; Yan W; Rodriguez-Canales J; Erickson HS; Hu N; Goldstein AM; Taylor PR; Richardson AM; Tangrea MA; Chuaqui RF; Emmert-Buck MR
J Transl Med; 2010 Oct; 8():91. PubMed ID: 20920372
[TBL] [Abstract][Full Text] [Related]
58. Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6.
Chryplewicz A; Tienda SM; Nahotko DA; Peters PN; Lengyel E; Eckert MA
Sci Rep; 2019 Mar; 9(1):5195. PubMed ID: 30914657
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of Ku80 correlates with aggressive clinicopathological features and adverse prognosis in esophageal squamous cell carcinoma.
Wang S; Wang Z; Yang YU; Shi MO; Sun Z
Oncol Lett; 2015 Nov; 10(5):2705-2712. PubMed ID: 26722230
[TBL] [Abstract][Full Text] [Related]
60. Cyclo-oxygenase-2 over-expression is associated with human esophageal squamous cell carcinoma.
Miyashita M; Makino H; Katsuta M; Nomura T; Shinji S; Kashiwabara M; Takahashi K; Kudo M; Ishiwata T; Naito Z; Tajiri T
J Nippon Med Sch; 2006 Dec; 73(6):308-13. PubMed ID: 17220580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
